Incyte (INCY) Gains (Losses) on Sale of Assets & Investments (2009 - 2026)
Incyte's Gains (Losses) on Sale of Assets & Investments was -$13.23 million in Q3 2026, compared with $8.56 million a year earlier.
Powered by 
Analysis
Incyte (INCY) Gains (Losses) on Sale of Assets & Investments (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Incyte's Gains (Losses) on Sale of Assets & Investments was $21.42 million through Sep 30, 2026; for FY2025, it was $21.31 million, down 81.6% from FY2024.
- In earlier years, Gains (Losses) on Sale of Assets & Investments was $116.03 million in FY2024 (+164.3%), $43.89 million in FY2023 and -$87.59 million in FY2022.
- The Q3 2026 figure marks the lowest quarterly Gains (Losses) on Sale of Assets & Investments since Q3 2023.
- Per Business Quant data, INCY's Gains (Losses) on Sale of Assets & Investments in the three quarters before Q3 2026 was $9.81 million (Q2 2026), $6.59 million (Q1 2026) and $18.25 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -13.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -13.23 Mn |
| Jun 30, 2026 | 9.81 Mn |
| Mar 31, 2026 | 6.59 Mn |
| Dec 31, 2025 | 18.25 Mn |
| Sep 30, 2025 | 8.56 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -1.34 Mn |
| Dec 31, 2024 | -10.18 Mn |
| Sep 30, 2024 | -12.98 Mn |
| Jun 30, 2024 | 39.24 Mn |
| Mar 31, 2024 | 99.95 Mn |
| Dec 31, 2023 | 34.05 Mn |
| Sep 30, 2023 | -26.65 Mn |
| Jun 30, 2023 | 41.81 Mn |
| Mar 31, 2023 | -5.32 Mn |
| Dec 31, 2022 | -15.45 Mn |
| Sep 30, 2022 | -660,000.00 |
| Jun 30, 2022 | -24.90 Mn |
| Mar 31, 2022 | -46.59 Mn |
| Dec 31, 2021 | 4.32 Mn |
API Access
Incyte Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();